Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cells

Carcinogenesis

Volumn 34, Issue 6, 2013, Pages 1361-1369

  Olsen, Anders Krüger ^a,b   Coskun, Mehmet ^b   Bzorek, Michael ^a   Kristensen, Michael Holmsgaard ^a   Danielsen, Erik Thomas ^b   Jørgensen, Steffen ^c,d   Olsen, Jørgen ^b   Engel, Ulla ^e   Holck, Susanne ^e   Troelsen, Jesper Thorvald ^d  

^a NAESTVED HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Lungemedicinsk Afdeling   (Denmark)

^d ROSKILDE UNIVERSITY   (Denmark)

^e Mental Health Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; AXIN; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; TRANSCRIPTION FACTOR CDX2;

ADULT; AGED; ANIMAL CELL; APC TUMOR SUPPRESSOR GENE; ARTICLE; AXIN2 TUMOR SUPPRESSOR GENE; CANCER CELL; CARCINOGENESIS; CELL MIGRATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENHANCER REGION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GSK3BETA TUMOR SUPPRESSOR GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AGED; AGED, 80 AND OVER; AXIN PROTEIN; BETA CATENIN; CACO-2 CELLS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HELA CELLS; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

EID: 84878980333     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt037     Document Type: Article

References (39)

1. Sparks,A.B. et al. (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58, 1130-1134.
2. Kinzler,K.W. et al. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
3. Brabletz,T et al. (2005) Invasion and metastasis in colorectal cancer: epithelial- mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs, 179, 56-65.
4. Spaderna,S. et al. (2006) A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology, 131, 830-840.
5. Gross,I. et al. (2008) The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cells. Oncogene, 27, 107-115.
6. Beck,F. et al. (1999) Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc. Natl. Acad. Sci. U.S.A., 96, 7318-7323.
7. Gao,N. et al. (2009) Establishment of intestinal identity and epithelialmesenchymal signaling by Cdx2. Dev. Cell, 16, 588-599.
8. Verzi,M.P. et al. (2010) Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Dev. Cell, 19, 713-726.
9. Boyd,M. et al. (2010) Genome-wide analysis of CDX2 binding in intestinal epithelial cells (Caco-2). J. Biol. Chem., 285, 25115-25125.
10. Olsen,A.K. et al. (2012) Current and emerging approaches to define intestinal epithelium-specific transcriptional networks. Am. J. Physiol. Gastrointest. Liver Physiol., 302, G277-G286.
11. Bakaris,S. et al. (2008) Expression of homeodomain protein CDX2 in colorectal adenoma and adenocarcinoma. Histol. Histopathol., 23, 1043-1047.
12. Aoki,K. et al. (2011) Suppression of colonic polyposis by homeoprotein CDX2 through its nontranscriptional function that stabilizes p27Kip1. Cancer Res., 71, 593-602.
13. Brabletz,T. et al. (2004) Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression. Cancer Res., 64, 6973-6977.
14. Subtil,C. et al. (2007) Frequent rearrangements and amplification of the CDX2 homeobox gene in human sporadic colorectal cancers with chromosomal instability. Cancer Lett., 247, 197-203.
15. Chawengsaksophak,K. et al. (1997) Homeosis and intestinal tumours in Cdx2 mutant mice. Nature, 386, 84-87.
16. Sancho,R. et al. (2009) JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J., 28, 1843-1854.
17. Guo,R.J. et al. (2010) The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the betacatenin- TCF protein complex. Carcinogenesis, 31, 159-166.
18. Hinkel,I. et al. (2012) Cdx2 controls expression of the protocadherin Mucdhl, an inhibitor of growth and β-catenin activity in colon cancer cells. Gastroenterology, 142, 875-885.e3.
19. Coskun,M. et al. (2012) TNF-a-induced down-regulation of CDX2 suppresses MEP1A expression in colitis. Biochim. Biophys. Acta, 1822, 843-851.
20. Frank,S.R. et al. (2001) Binding of c-Myc to chromatin mediates mitogeninduced acetylation of histone H4 and gene activation. Genes Dev., 15, 2069-2082.
21. Coskun,M. et al. (2010) Control of intestinal promoter activity of the cellular migratory regulator gene ELMO3 by CDX2 and SP1. J. Cell. Biochem., 109, 1118-1128.
22. Dydensborg,A.B. et al. (2006) Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. Am. J. Physiol. Gastrointest. Liver Physiol, 290, G1067-1074.
23. Boyd,M. et al. (2009) Mapping of HNF4alpha target genes in intestinal epithelial cells. BMC Gastroenterol., 9, 68.
24. Matys,V. et al. (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res., 31, 374-378.
25. Li,X.Y. et al. (2008) Transcription factors bind thousands of active and inactive regions in the Drosophila blastoderm. PLoS Biol., 6, e27.
26. Janssen,K.P. et al. (2006) APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology, 131, 1096-1109.
27. Lammi,L. et al. (2004) Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am. J. Hum. Genet., 74, 1043-1050.
28. Visel,A. et al. (2009) ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature, 457, 854-858.
29. Jaiswal,A.S. et al. (2001) Upstream stimulating factor-1 (USF1) and USF2 bind to and activate the promoter of the adenomatous polyposis coli (APC) tumor suppressor gene. J. Cell Biochem., 81, 262-277.
30. Nagel,R. et al. (2008) Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res., 68, 5795-5802.
31. Laurent,C. et al. (2011) Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer. Inflamm. Bowel Dis., 17, 232-240.
32. Fodde,R. et al. (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer, 1, 55-67.
33. Lustig,B. et al. (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol., 22, 1184-1193.
34. Verzi,M.P. et al. (2010) TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions. Proc. Natl. Acad. Sci. U.S.A., 107, 15157-15162.
35. Wang,J. et al. (2012) Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res., 22, 1798-1812.
36. Hirakawa,H. et al. (2009) Apical membrane localization of glycogen synthase kinase 3beta protein in normal colon epithelium and aberrant distribution in colorectal cancer. Cancer Lett., 275, 158-162.
37. Hoeflich,K.P. et al. (2000) Requirement for glycogen synthase kinase- 3beta in cell survival and NF-kappaB activation. Nature, 406, 86-90.
38. Ougolkov,A.V. et al. (2006) Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation. Clin. Cancer Res., 12, 5074-5081.
39. Terzic,J. et al. (2010) Inflammation and colon cancer. Gastroenterology, 138, 2101-2114.e5.